Patrick Soon-Shiong announces Long Covid trial in California

Patrick Soon-Shiong, renowned billionaire and health innovator, has made public plans to initiate a clinical trial aimed at exploring treatments for Long Covid in California.
The trial is expected to open shortly, according to Soon-Shiong's announcement on social media. Notably, it will be conducted under the aegis of the Chan Soon-Shiong Institute for Medicine. This effort marks another step in the healthcare sector's ongoing efforts to address the lingering effects experienced by many Covid-19 survivors.
Long Covid has been identified as a significant post-viral syndrome affecting various aspects of health and quality of life, necessitating diverse medical interventions. Researchers and healthcare professionals are keen to investigate potential therapies that could relieve patients who suffer from this condition.
The trial builds upon existing work done under the ''Bioshield'' initiative, which seeks to innovate and provide crucial healthcare solutions. Interested parties can find further details on the institute's official website. It is a promising development in the field of healthcare and pandemic recovery.
Loading...